ContraFect Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,145.30
27,393.10
32,921.70
35,161.20
46,853.90
30,452.30
Other Current Assets
198.40
368.80
1,176.90
1,017.60
1,848.10
786.80
Total Current Assets
4,343.70
27,761.80
34,098.50
36,178.80
48,702.00
31,441.10
Net Property, Plant & Equipment
2,735.20
2,148.20
1,619.00
1,281.20
1,093.90
1,076.10
Total Investments and Advances
25.00
-
-
-
-
-
Other Assets
2,580.00
143.60
143.60
164.50
393.60
355.40
Total Assets
9,683.80
30,053.60
35,861.10
37,624.50
50,189.50
32,872.60
Accounts Payable
2,124.90
481.60
-
-
1,302.40
Other Current Liabilities
4,991.90
3,677.50
3,769.20
4,418.20
3,118.20
Total Current Liabilities
7,116.80
4,159.10
3,769.20
4,418.20
4,420.70
Long-Term Debt
12,497.10
-
-
-
-
Other Liabilities
3,088.00
313.00
1,416.40
13,693.40
14,575.40
Total Liabilities
22,702.00
4,472.10
5,185.60
18,111.60
18,996.00
Common Equity (Total)
52,910.50
25,581.50
30,675.50
19,512.90
31,193.40
Total Shareholders' Equity
13,018.20
25,581.50
30,675.50
19,512.90
31,193.40
Total Equity
13,018.20
25,581.50
30,675.50
19,512.90
31,193.40
Liabilities & Shareholders' Equity
9,683.80
30,053.60
35,861.10
37,624.50
50,189.50
Preferred Stock (Carrying Value)
39,892.30
-
-
-
-

About ContraFect

View Profile
Address
28 Wells Avenue
Yonkers New York 10701
United States
Employees -
Website http://www.contrafect.com
Updated 07/08/2019
ContraFect Corp. engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.